US Stocks
/
Genprex, Inc. Share Price
Genprex, Inc. Share Price

Genprex, Inc. Share Price

NASDAQ: GNPX | Micro Cap
$2.71
-$0.05 (-1.81%) Last updated on 10 Oct, 2026 | 00:40 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Genprex, Inc. Stock Performance

Open
$2.83
Prev. Close
$2.76
Circuit Range
N/A
Day Range
$2.66 - $2.86
Year Range
$0.17 - $11.21
Volume
1,705
Average Traded
$2.78

Genprex, Inc. Share Price Today

As of 10 October 2026, Genprex, Inc.'s share price is $2.71. The stock opened at $2.83, compared to its previous close of $2.76. During today's trading session, Genprex, Inc.'s share price traded between $2.66 and $2.86, with an average price of $2.76. Over the past 52 weeks, the stock has recorded a high of $11.21 and a low of $0.17. In terms of performance, Genprex, Inc.'s share price has risen by 178.52% over the last six months and is down 53.11% on a year-on-year basis.

Genprex, Inc. Share Price Chart

$2.66$2.86
L
Show Current Price
H

Genprex, Inc. Stock Fundamentals & Key Indicators

Market Cap
$2.53M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-20.13
Revenue (TTM)
$0.00
Return On Equity (TTM)
-111.51%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-17.11%

Genprex, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$3.80-$3.79-$4.46-$4.45
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A0.26%-17.68%0.22%

Genprex, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$23.74-$30.86-$21.39-$16.23
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-29.99%30.69%24.12%

About Genprex, Inc.

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System, which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Gene Therapy (quaratusugene ozeplasmid), is initially being developed in combination with prominent, approved cancer drugs to treat Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC).

Genprex, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$2.83
$2.68
-9.15%
Sep 2026
$3.56
$2.95
-26.98%
Aug 2026
$4.87
$4.04
-32.21%
Jul 2026
$0.55
$5.96
+1,059.53%
Jun 2026
$0.76
$0.51
-34.10%
May 2026
$0.94
$0.78
-19.84%
Apr 2026
$1.75
$0.97
-44.87%
Mar 2026
$1.90
$1.76
-11.75%
Feb 2026
$2.67
$2.00
-24.53%
Jan 2026
$1.77
$2.65
+52.30%
Dec 2025
$2.85
$1.74
-40.61%
Nov 2025
$5.76
$2.93
-49.31%

GNPX Share Price FAQs

What is Genprex, Inc. share price today?

chevron-up
Genprex, Inc. share price today is $2.71 as on October 10, 2026 at 12:40 am IST.

What is the 52 week high and 52 week low of Genprex, Inc. stock?

chevron-up
The 52 week high of Genprex, Inc. stock is $11.21, while the 52 week low is $0.17 as of 10 Oct '26.

What is GNPX's market capitalisation today?

chevron-up
GNPX market capitalisation is $2.53M as of October 10, 2026, at 12:41 am IST.

What is GNPX's net income for the last quarter?

chevron-up
GNPX's net income for the last quarter is -4.45B USD.

What is the 5 year returns of GNPX?

chevron-up
The 5 year returns of GNPX is -97.09% as on 10 Oct '26.

What is the high & low stock price of GNPX today?

chevron-up
GNPX stock price hit a high of $2.86 and low of $2.66 as of 10 Oct '26.

Can I buy GNPX shares in India?

chevron-up
Yes. You can buy GNPX in India by opening an international trading account.